Austrianova is one company that does services that links high tech, life sciences and biotech.

It is complemented with an encapsulation technology with the living cells in bio-inery polymers. In short, we are a life science based firm that concentrate in the indusion of living cells or bacteria in small capsules for defense which is also recognized as cell encapsulation technology, isolation, storage and transportation. We were first built in the year 2007 and was built in Singapore's best exploration biotech hub, Biopolis that has large-scale vision in supporting encapsulation choices like micro encapsulation.

There is a fast increasing subject of attention in healthy maintenance and more precise, in the subject of neutraceuticals which is the comprehension and use of probiotic bacteria. Hence, probiotics encapsulation was built. The cell-in-a-box technology was built by Austranova with the goal to keep safe, isolate, collect and deliver living cells. This proprietary creation can be used for numerous reasons and can be joined to probiotics, cosmetics and agriculture environmental protection and screening as well as creating the base of a influential exploration device.

In healthcare, this technology aids controloperate safe implantation of cells or stem cells such as cell therapy, holding them separated from the immune system and permitting long term making of therapeutic molecules in patients. In biotechnology, the cell-in-a-box creation guards cells in bioreactors and fermentors and at the same time, it simplifies cleansing of bioproducts produced from the cells and it reduces manufacture price too.

A wide rule cGMP facility for the production of biomedical grade encapsulated cell tools was previously fruitfully formed and right now, Austrianova is in the procedure of setting up this capability in the whole of SE Asia. This means the use of cell-in-a-box was quite a success for pancreatic cancer! Basically, it is the use of encapsulated cells for cancer cell therapy from genetically modified cells over-expressing a chemo-activating enzyme to permit minor dosages of chemotherapy to be used more productively without the common debilitating side consequences. The encapsulated cell are sited, using supraselective catheterisation, into blood vessels that flows to the tumor where they locally change a chemotherapeutic product to its tumor toxic product.

Come to our site for additional information: Encapsulation Services, Cell Therapy , Stem Cells.